Insider · CIK 0001702035
Taryn D. Fielder
Files at VRE (Veris Residential, Inc.). First filing -, latest -.
In brief
Taryn D. Fielder files SEC Form 4 as officer at VRE (Veris Residential, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Taryn D. Fielder has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 30 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 27, 2026 | VRE Veris Residential, Inc. | DDisposition to issuer Common Stock, $0.01 par value | -138,330 | - | - | 0 | May 27, 2026 |
| May 27, 2026 | VRE Veris Residential, Inc. | DDisposition to issuer Performance Vesting Restricted Stock Unitsderivative | -105,767 | - | - | 0 | May 27, 2026 |
| May 27, 2026 | VRE Veris Residential, Inc. | DDisposition to issuer Outperformance Vesting Restricted Stock Unitsderivative | -23,585 | - | - | 0 | May 27, 2026 |
| Mar 16, 2026 | VRE Veris Residential, Inc. | MOption exercise Common Stock, $0.01 par value | +28,693 | - | - | 153,834 | Mar 18, 2026 |
| Mar 16, 2026 | VRE Veris Residential, Inc. | FTax withholding Common Stock, $0.01 par value | -11,570 | $18.89 | $219k | 142,264 | Mar 18, 2026 |
| Mar 17, 2026 | VRE Veris Residential, Inc. | FTax withholding Common Stock, $0.01 par value | -3,934 | $18.88 | $74k | 138,330 | Mar 18, 2026 |
| Mar 16, 2026 | VRE Veris Residential, Inc. | MOption exercise Performance Vesting Restricted Stock Unitsderivative | -34,102 | - | - | 0 | Mar 18, 2026 |
| Mar 12, 2026 | VRE Veris Residential, Inc. | FTax withholding Common Stock, $0.01 par value | -2,369 | $18.87 | $45k | 125,141 | Mar 16, 2026 |
| Mar 9, 2026 | VRE Veris Residential, Inc. | FTax withholding Common Stock, $0.01 par value | -2,124 | $18.85 | $40k | 127,510 | Mar 11, 2026 |
| Feb 19, 2026 | VRE Veris Residential, Inc. | AGrant or award Time Vesting Restricted Stock Units | +23,585 | $0.00 | $0 | 129,634 | Feb 23, 2026 |
| Feb 19, 2026 | VRE Veris Residential, Inc. | AGrant or award Performance Vesting Restricted Stock Unitsderivative | +23,584 | $0.00 | $0 | 23,584 | Feb 23, 2026 |
| Feb 19, 2026 | VRE Veris Residential, Inc. | AGrant or award Outperformance Vesting Restricted Stock Unitsderivative | +23,585 | $0.00 | $0 | 23,585 | Feb 23, 2026 |
| Apr 29, 2025 | VRE Veris Residential, Inc. | MOption exercise Common Stock, $0.01 par value | +17,489 | - | - | 116,323 | May 1, 2025 |
| Apr 29, 2025 | VRE Veris Residential, Inc. | FTax withholding Common Stock, $0.01 par value | -10,274 | $15.36 | $158k | 106,049 | May 1, 2025 |
| Apr 29, 2025 | VRE Veris Residential, Inc. | MOption exercise Outperformance Vesting Restricted Stock Unitsderivative | -17,489 | - | - | 0 | May 1, 2025 |
| Apr 18, 2025 | VRE Veris Residential, Inc. | FTax withholding Common Stock, $0.01 par value | -1,474 | $15.57 | $23k | 98,834 | Apr 21, 2025 |
| Mar 17, 2025 | VRE Veris Residential, Inc. | FTax withholding Common Stock, $0.01 par value | -2,625 | $16.27 | $43k | 100,308 | Mar 19, 2025 |
| Mar 12, 2025 | VRE Veris Residential, Inc. | FTax withholding Common Stock, $0.01 par value | -2,369 | $16.14 | $38k | 102,933 | Mar 14, 2025 |
| Mar 10, 2025 | VRE Veris Residential, Inc. | MOption exercise Common Stock, $0.01 par value | +7,310 | - | - | 107,502 | Mar 12, 2025 |
| Mar 10, 2025 | VRE Veris Residential, Inc. | FTax withholding Common Stock, $0.01 par value | -2,200 | $16.58 | $36k | 105,302 | Mar 12, 2025 |
| Mar 10, 2025 | VRE Veris Residential, Inc. | MOption exercise Performance Vesting Restricted Stock Unitsderivative | -23,159 | - | - | 0 | Mar 12, 2025 |
| Mar 7, 2025 | VRE Veris Residential, Inc. | AGrant or award Time Vesting Restricted Stock Units | +21,174 | $0.00 | $0 | 100,192 | Mar 11, 2025 |
| Mar 7, 2025 | VRE Veris Residential, Inc. | AGrant or award Performance Vesting Restricted Stock Unitsderivative | +20,644 | $0.00 | $0 | 20,644 | Mar 11, 2025 |
| Mar 7, 2025 | VRE Veris Residential, Inc. | AGrant or award Outperformance Vesting Restricted Stock Unitsderivative | +21,174 | $0.00 | $0 | 21,174 | Mar 11, 2025 |
| Apr 29, 2024 | VRE Veris Residential, Inc. | FTax withholding Common Stock, $0.01 par value | -1,755 | $14.62 | $26k | 58,538 | May 1, 2024 |
| Mar 18, 2024 | VRE Veris Residential, Inc. | FTax withholding Common Stock, $0.01 par value | -2,626 | $14.81 | $39k | 60,293 | Mar 20, 2024 |
| Mar 12, 2024 | VRE Veris Residential, Inc. | AGrant or award Time Vesting Restricted Stock Units | +23,617 | $0.00 | $0 | 62,919 | Mar 14, 2024 |
| Mar 12, 2024 | VRE Veris Residential, Inc. | AGrant or award Performance Vesting Restricted Stock Unitsderivative | +25,524 | $0.00 | $0 | 25,524 | Mar 14, 2024 |
| Mar 12, 2024 | VRE Veris Residential, Inc. | AGrant or award Outperformance Vesting Restricted Stock Unitsderivative | +23,617 | $0.00 | $0 | 23,617 | Mar 14, 2024 |
| Jan 4, 2024 | VRE Veris Residential, Inc. | FTax withholding Common Stock, $0.01 par value | -1,732 | $15.79 | $27k | 59,782 | Jan 12, 2024 |
Questions about Taryn D. Fielder
Answered from the filings on this page, as of the latest one.
Is Taryn D. Fielder buying or selling?
Taryn D. Fielder has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Taryn D. Fielder's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Taryn D. Fielder has 0.
Where does Taryn D. Fielder file Form 4?
Taryn D. Fielder has filed Form 4 at VRE (Veris Residential, Inc.) as EVP, GENERAL COUNSEL & SEC.. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.